BPLSX
Price
$14.96
Change
-$0.12 (-0.80%)
Updated
Nov 13 closing price
Net Assets
91.73M
NLSCX
Price
$18.84
Change
-$0.08 (-0.42%)
Updated
Nov 13 closing price
Net Assets
8.07B
Interact to see
Advertisement

BPLSX vs NLSCX

Header iconBPLSX vs NLSCX Comparison
Open Charts BPLSX vs NLSCXBanner chart's image
Boston Partners Long/Short Equity Instl
Price$14.96
Change-$0.12 (-0.80%)
VolumeN/A
Net Assets91.73M
Neuberger Berman Long Short C
Price$18.84
Change-$0.08 (-0.42%)
VolumeN/A
Net Assets8.07B
BPLSX vs NLSCX Comparison Chart in %
View a ticker or compare two or three
VS
BPLSX vs. NLSCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPLSX is a Hold and NLSCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 8.07B vs. BPLSX (91.7M). BPLSX pays higher dividends than NLSCX: BPLSX (0.48) vs NLSCX (0.00). BPLSX was incepted earlier than NLSCX: BPLSX (27 years) vs NLSCX (14 years). BPLSX (2.72) is less costly to investors than NLSCX (2.43). NLSCX is a more actively managed with annual turnover of: 48.00 vs. BPLSX (35.00). NLSCX has a lower initial minimum investment than BPLSX: NLSCX (1000) vs BPLSX (100000). NLSCX annual gain was more profitable for investors over the last year : 6.56 vs. BPLSX (-3.14). NLSCX return over 5 years is better than : 16.09 vs. BPLSX (-5.43).
BPLSXNLSCXBPLSX / NLSCX
Total Expense Ratio2.042.4384%
Annual Report Gross Expense Ratio2.722.43112%
Fund Existence27 years14 years-
Gain YTD22.2226.501342%
Front LoadN/AN/A-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets91.7M8.07B1%
Annual Yield % from dividends0.480.00-
Returns for 1 year-3.146.56-48%
Returns for 3 years-0.5819.01-3%
Returns for 5 years-5.4316.09-34%
Returns for 10 years-23.6546.51-51%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBIGF0.28N/A
+0.07%
Paradigm Biopharmaceuticals Ltd.
ELSSF28.97N/A
N/A
ELIS
CHRHF2.22N/A
N/A
CHERVON HLDGS LTD.
AICOF0.13N/A
N/A
Generative AI Solutions Corp.
HCMLF94.80N/A
N/A
HOLCIM LTD